EXPRESSION OF THE APC GENE AFTER TRANSFECTION INTO A COLONIC-CANCER CELL-LINE

被引:22
|
作者
HARGEST, R [1 ]
WILLIAMSON, R [1 ]
机构
[1] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND
关键词
FAMILIAL ADENOMATOUS POLYPOSIS; ADENOMATOUS POLYPOSIS COLI; GENE THERAPY; LIPOFECTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RESTRICTION ENZYME DIGESTION;
D O I
10.1136/gut.37.6.826
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mutations in the adenomatous polyposis coli (APC) gene cause the hereditary cancer syndrome familial adenomatous polyposis and are implicated in the early stages of sporadic colorectal carcinogenesis. APC is therefore a promising candidate for use in prophylactic gene therapy of intestinal tissues at high risk of becoming malignant. The aim of the study was to discover if functional full length APC gene can be introduced into somatic gut epithelial cells and to define the optimum conditions for such transfer. Copies of the normal APC gene were introduced into SW480 cells, a colonic epithelial cell Line with an APC gene mutation, using plasmid DNA combined with liposomes. Reverse transcriptase polymerase chain reaction and restriction enzyme digestion allowed the endogenous gene to be distinguished from the transgene. It was shown that the normal APC gene is expressed at high levels for 72 hours after transfection and disappears within one week. This study shows that short-term expression of normal APC gene can be achieved after transfection with liposome-DNA complexes at sufficiently high levels to permit assessment of biological effects.
引用
收藏
页码:826 / 829
页数:4
相关论文
共 50 条
  • [1] LIPOSOME-MEDIATED DELIVERY OF THE ADENOMATOUS POLYPOSIS-COLI GENE INTO A COLONIC-CANCER CELL-LINE
    HARGEST, R
    WILLIAMSON, R
    BRITISH JOURNAL OF SURGERY, 1995, 82 (05) : 691 - 691
  • [2] INCREASED MDR GENE-EXPRESSION AND DECREASED DRUG ACCUMULATION IN A HUMAN COLONIC-CANCER CELL-LINE RESISTANT TO HYDROPHOBIC DRUGS
    CHAO, CCK
    MA, CM
    CHENG, PW
    LINCHAO, S
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (02) : 842 - 849
  • [3] OCTREOTIDE INHIBITS DEVELOPMENT OF HEPATIC METASTASES FROM A HUMAN COLONIC-CANCER CELL-LINE
    STEWART, GJ
    LAWSON, JA
    MORRIS, DL
    BRITISH JOURNAL OF SURGERY, 1994, 81 (09) : 1332 - 1332
  • [4] SECRETAGOGUE ACTION ON MEMBRANE VOLTAGE OF COLONIC-CANCER CELL-LINE HT-29
    ZISS, W
    FROMM, M
    HEGEL, U
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY A-PHYSIOLOGY, 1988, 90 (04): : 837 - 837
  • [5] EMERGENCE OF PERMANENTLY DIFFERENTIATED CELL CLONES IN A HUMAN COLONIC-CANCER CELL-LINE IN CULTURE AFTER TREATMENT WITH SODIUM-BUTYRATE
    AUGERON, C
    LABOISSE, CL
    CANCER RESEARCH, 1984, 44 (09) : 3961 - 3969
  • [6] INSULIN BINDING BY A CELL-LINE (HT-29) DERIVED FROM HUMAN COLONIC-CANCER
    FORGUELAFITTE, ME
    HORVAT, A
    ROSSELIN, G
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1979, 14 (02) : 123 - 130
  • [7] A MUCUS-SECRETING HUMAN COLONIC-CANCER CELL-LINE - PURIFICATION AND PARTIAL CHARACTERIZATION OF THE SECRETED MUCINS
    MAORET, JJ
    FONT, J
    AUGERON, C
    CODOGNO, P
    BAUVY, C
    AUBERY, M
    LABOISSE, CL
    BIOCHEMICAL JOURNAL, 1989, 258 (03) : 793 - 799
  • [8] OLIGOSACCHARIDE STRUCTURES OF MUCINS SECRETED BY THE HUMAN COLONIC-CANCER CELL-LINE CL.16E
    CAPON, C
    LABOISSE, CL
    WIERUSZESKI, JM
    MAORET, JJ
    AUGERON, C
    FOURNET, B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (27) : 19248 - 19257
  • [9] VASCULARIZATION OF THE CONTINUOUS HUMAN COLONIC-CANCER CELL-LINE LS-174-T DEPOSITED SUBCUTANEOUSLY IN NUDE RATS
    AHLSTROM, H
    CHRISTOFFERSON, R
    LORELIUS, LE
    APMIS, 1988, 96 (08) : 701 - 710
  • [10] IN-VITRO ASSAY OF THE EFFECTS OF BOMBESIN AND ANTAGONISTS ON HUMAN COLONIC-CANCER CELL-LINE COLO320HSR
    PRESTON, SR
    RAMSDEN, CW
    MILLER, GV
    PRIMROSE, JN
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1818 - 1818